Analysis & Separations Science Industry Insights

Molecular structure emerging from capsules, symbolizing drug discovery in functional proteomics.

Industry Insight

Advancing Drug Discovery With Functional Proteomics

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate instrumentation, software and consumables to support early-stage pharma innovation.

A digital illustration depicted a number of small molecule structures, with a glass-like appearance.

Industry Insight

Advancing Small Molecule Analysis For PFAS, Drugs and Contamination Detection

Learn how Bruker’s latest innovations are enhancing small molecule analysis for toxicology and environmental analysis.

3D molecular structure showing protein fragments.

Industry Insight

Transforming Sample Prep for Mass Spectrometry

At the recent American Society for Mass Spectrometry conference in Baltimore, Technology Networks sat down with Dr. Nikhil Rao to learn more about Microscoop® Mint, an advanced sample preparation platform.

Industry Insight

Overcoming In Vivo Delivery Challenges With Image-Guided Innovation

Dr. Tomek Czernuszewicz shares insights on the limitations of traditional delivery techniques and how Revvity is advancing in vivo imaging through AI-powered tools.

3D stick and ball molecular structure emerging from a red drug capsule.

Industry Insight

Faster, More Confident Small Molecule Structure Verification in Pharmaceutical R&D

Structure verification by NMR is a vital task in drug discovery but can be slow and subjective. This article explores how ASV transforms it into a scalable, consistent and reliable process.

Doctor wearing a white coat and stethoscope lining up letter tiles to spell Vitamin D.

Industry Insight

How Mass Spectrometry Is Refining Vitamin D Testing

Explore the clinical impact of accurate vitamin D measurement, how the cobas® Mass Spec solution enhances diagnostic precision and the broader role of clinical mass spectrometry in advancing personalized healthcare.

Doctor holding holographic human figure symbolizing clinical mass spectrometry diagnostics.

Industry Insight

Bruker’s Investment in RECIPE Expands Access to Chromatography-Free MS

Chromatography-free mass spectrometry boosts throughput, cuts costs and simplifies drug monitoring – learn how Bruker and RECIPE are leading the way.

3D molecular rendering of a protein structure illustrating complexity in proteomics research.

Industry Insight

Unlocking Next-Gen Capabilities in LC-MS-Based Proteomics

In this interview, Morten Bern, chief executive officer of Evosep, discusses the innovations behind the Eno system, the evolving needs of pharmaceutical customers and the growing focus on high-throughput, high-sensitivity proteomics solutions.